Back
Pharming Group Vs. ProQR Therapeutics NV Industry Stock Comparison
Sell
42
PHAR
Pharming Group
Last Price:
7.54
Seasonality Move:
-9.32%
Sell
25
PRQR
ProQR Therapeutics NV
Last Price:
1.72
Seasonality Move:
-1.1%
Sell
42
Pharming Group (PHAR)
is a Sell
Is Pharming Group a Buy, Sell or Hold?
- The current Pharming Group [PHAR] share price is $7.59. The Score for PHAR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- PHAR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
ProQR Therapeutics NV (PRQR)
is a Sell
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $1.73. The Score for PRQR is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- PRQR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAR Stock Price Chart
What is Pharming Group's stock price today?
-
The Pharming Group share price today is $7.59
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAR is experiencing slight selling pressure.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $1.73
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
PHAR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 48.35 | Sell |
Chaikin Money Flow: | -982 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.31 - 7.97) | Sell |
Bollinger Bands (100): | (7.57 - 9.15) | Sell |
PRQR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 30.02 | Sell |
Chaikin Money Flow: | -51308 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.81 - 2.07) | Sell |
Bollinger Bands (100): | (1.74 - 2.02) | Sell |
PHAR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.68 | Sell |
20-day SMA: | 7.57 | Buy |
50-day SMA: | 7.88 | Sell |
200-day SMA: | 9.91 | Sell |
8-day EMA: | 7.7 | Sell |
20-day EMA: | 7.65 | Sell |
50-day EMA: | 7.88 | Sell |
200-day EMA: | 9.39 | Sell |
PRQR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.82 | Sell |
20-day SMA: | 1.9 | Sell |
50-day SMA: | 1.92 | Sell |
200-day SMA: | 1.99 | Sell |
8-day EMA: | 1.81 | Sell |
20-day EMA: | 1.87 | Sell |
50-day EMA: | 1.9 | Sell |
200-day EMA: | 1.91 | Sell |
Pharming Group Earnings Growth & PHAR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
Pharming Group Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
ProQR Therapeutics NV Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |